Role of BRD4 in hematopoietic differentiation of embryonic stem cells

Epigenetics

Volumn 9, Issue 4, 2014, Pages 566-578

  Rodriguez, Ramon M ^a,b   Suarez Alvarez, Beatriz ^b   Salvanés, Ruben ^b   Huidobro, Covadonga ^a,c   Toraño, Estela G ^a   Garcia Perez, Jose L ^d   Lopez Larrea, Carlos ^b,e   Fernandez, Agustin F ^a   Bueno, Clara ^d,f   Menendez, Pablo ^f,g   Fraga, Mario F ^a,h  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF GRANADA   (Spain)

^e Section of Nephrology   (Spain)

^f JOSEP CARRERAS LEUKAEMIA RESEARCH INSTITUTE IJC   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

BRD4; Bromodomain; Differentiation; Hematopoiesis; Stem cells

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; LIPOCORTIN 5; MYC PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRD4; UNCLASSIFIED DRUG; BRD4 PROTEIN, HUMAN; MYC PROTEIN, HUMAN; NUCLEAR PROTEIN;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOID CELL; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; CYTOLOGY; FETUS BLOOD; GENETIC EPIGENESIS; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; METABOLISM; NEWBORN; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELL LINE; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FETAL BLOOD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84899137307     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.27711     Document Type: Article

References (47)

1. Dey A, Ellenberg J, Farina A, Coleman AE, Maruyama T, Sciortino S, Lippincott-Schwartz J, Ozato K. A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol Cell Biol 2000; 20:6537-49; PMID:10938129; http://dx.doi.org/10.1128/ MCB.20.17.6537-6549.2000
2. Chiang CM. Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4. F1000 Biol Rep 2009; 1:98; PMID:20495683
3. Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 2005; 19:523-34; PMID:16109376; http:// dx.doi.org/10.1016/j.molcel.2005.06.027
4. Dey A, Nishiyama A, Karpova T, McNally J, Ozato K. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell 2009; 20:4899-909; PMID:19812244; http://dx.doi. org/10.1091/mbc.E09-05-0380
5. Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009; 138:129-45; PMID:19596240; http://dx.doi.org/10.1016/j. cell.2009.05.047
6. Maruyama T, Farina A, Dey A, Cheong J, Bermudez VP, Tamura T, Sciortino S, Shuman J, Hurwitz J, Ozato K. A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol 2002; 22:6509-20; PMID:12192049; http://dx.doi.org/10.1128/ MCB.22.18.6509-6520.2002
7. Houzelstein D, Bullock SL, Lynch DE, Grigorieva EF, Wilson VA, Beddington RS. Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4. Mol Cell Biol 2002; 22:3794-802; PMID:11997514; http:// dx.doi.org/10.1128/MCB.22.11.3794-3802.2002
8. You J, Li Q, Wu C, Kim J, Ottinger M, Howley PM. Regulation of aurora B expression by the bromodomain protein Brd4. Mol Cell Biol 2009; 29:5094-103; PMID:19596781; http://dx.doi.org/10.1128/ MCB.00299-09
9. French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 2003; 63:304-7; PMID:12543779
10. French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004; 22:4135-9; PMID:15483023; http://dx.doi.org/10.1200/ JCO.2004.02.107
11. Mertz JA, Conery AR, Bryant BM, Sandy P, Balasubramanian S, Mele DA, Bergeron L, Sims RJ 3rd. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A 2011; 108:16669-74; PMID:21949397; http:// dx.doi.org/10.1073/pnas.1108190108
12. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011; 478:524-8; PMID:21814200; http://dx.doi. org/10.1038/nature10334
13. Crawford NP, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, Lee MP, Ozato K, Hunter KW. Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci U S A 2008; 105:6380-5; PMID:18427120; http://dx.doi. org/10.1073/pnas.0710331105
14. Rodriguez RM, Huidobro C, Urdinguio RG, Mangas C, Soldevilla B, Domínguez G, Bonilla F, Fernandez AF, Fraga MF. Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer. J Mol Med (Berl) 2012; 90:587-95; PMID:22120039; http:// dx.doi.org/10.1007/s00109-011-0837-0
15. Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Gonzalez A, Gazdar AF, Minna JD, Carbone DP, Dang TP. Cloned fusion product from a rare t(15;19) (q13.2;p13.1) inhibit S phase in vitro. J Med Genet 2005; 42:558-64; PMID:15994877; http://dx.doi. org/10.1136/jmg.2004.029686
16. French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, Kutok JL, Toretsky JA, Tadavarthy AK, Kees UR, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 2008; 27:2237-42; PMID:17934517; http://dx.doi. org/10.1038/sj.onc.1210852
17. Yan J, Diaz J, Jiao J, Wang R, You J. Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma. J Biol Chem 2011; 286:27663-75; PMID:21652721; http://dx.doi.org/10.1074/jbc. M111.246975
18. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454:766-70; PMID:18600261
19. Borgel J, Guibert S, Li Y, Chiba H, Schübeler D, Sasaki H, Forné T, Weber M. Targets and dynamics of promoter DNA methylation during early mouse development. Nat Genet 2010; 42:1093-100; PMID:21057502; http://dx.doi.org/10.1038/ng.708
20. Saito S, Aoki H, Ito A, Ueno S, Wada T, Mitsuzuka K, Satoh M, Arai Y, Miyagi T. Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase. J Biol Chem 2003; 278:26474-9; PMID:12716912; http://dx.doi.org/10.1074/jbc. M213223200
21. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005; 105:617-26; PMID:15374881; http://dx.doi.org/10.1182/blood-2004-04-1649
22. Wang L, Li L, Shojaei F, Levac K, Cerdan C, Menendez P, Martin T, Rouleau A, Bhatia M. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004; 21:31-41; PMID:15345218; http://dx.doi. org/10.1016/j.immuni.2004.06.006
23. Ramos-Mejia V, Melen GJ, Sanchez L, Gutierrez-Aranda I, Ligero G, Cortes JL, Real PJ, Bueno C, Menendez P. Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther 2010; 18:2173-81; PMID:20736931; http://dx.doi. org/10.1038/mt.2010.179
24. Bueno C, Montes R, Melen GJ, Ramos-Mejia V, Real PJ, Ayllón V, Sanchez L, Ligero G, Gutierrez-Aranda I, Fernández AF, et al. A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification. Cell Res 2012; 22:986-1002; PMID:22212479; http:// dx.doi.org/10.1038/cr.2012.4
25. Bueno C, Ayllón V, Montes R, Navarro-Montero O, Ramos-Mejia V, Real PJ, Romero-Moya D, Araúzo-Bravo MJ, Menendez P. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs. Blood. 2013; 121:3867-78, S1-3.
26. Yang Z, He N, Zhou Q. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol Cell Biol 2008; 28:967-76; PMID:18039861; http://dx.doi. org/10.1128/MCB.01020-07
27. Dubois NC, Adolphe C, Ehninger A, Wang RA, Robertson EJ, Trumpp A. Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development 2008; 135:2455-65; PMID:18550708; http://dx.doi.org/10.1242/dev.022707
28. Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, Frazier J, Chau BN, Loboda A, Linsley PS, et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci U S A 2012; 109:9545-50; PMID:22623531; http://dx.doi.org/10.1073/pnas.1121119109
29. Lamonica JM, Deng W, Kadauke S, Campbell AE, Gamsjaeger R, Wang H, Cheng Y, Billin AN, Hardison RC, Mackay JP, et al. Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes. Proc Natl Acad Sci U S A 2011; 108:E159-68; PMID:21536911; http://dx.doi.org/10.1073/ pnas.1102140108
30. Shang E, Nickerson HD, Wen D, Wang X, Wolgemuth DJ. The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation. Development 2007; 134:3507-15; PMID:17728347; http://dx.doi. org/10.1242/dev.004481
31. Gaucher J, Boussouar F, Montellier E, Curtet S, Buchou T, Bertrand S, Hery P, Jounier S, Depaux A, Vitte AL, et al. Bromodomain-dependent stage-specific male genome programming by Brdt. EMBO J 2012; 31:3809-20; PMID:22922464; http://dx.doi. org/10.1038/emboj.2012.233
32. Tsume M, Kimura-Yoshida C, Mochida K, Shibukawa Y, Amazaki S, Wada Y, Hiramatsu R, Shimokawa K, Matsuo I. Brd2 is required for cell cycle exit and neuronal differentiation through the E2F1 pathway in mouse neuroepithelial cells. Biochem Biophys Res Commun 2012; 425:762-8; PMID:22885183; http://dx.doi.org/10.1016/j.bbrc.2012.07.149
33. Calvanese V, Horrillo A, Hmadcha A, Suarez-Alvarez B, Fernandez AF, Lara E, Casado S, Menendez P, Bueno C, Garcia-Castro J, et al. Cancer genes hypermethylated in human embryonic stem cells. PLoS One 2008; 3:e3294; PMID:18820729; http:// dx.doi.org/10.1371/journal.pone.0003294
34. Ji H, Ehrlich LI, Seita J, Murakami P, Doi A, Lindau P, Lee H, Aryee MJ, Irizarry RA, Kim K, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010; 467:338-42; PMID:20720541; http://dx.doi. org/10.1038/nature09367
35. Bocker MT, Hellwig I, Breiling A, Eckstein V, Ho AD, Lyko F. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood 2011; 117:e182-9; PMID:21427290; http://dx.doi. org/10.1182/blood-2011-01-331926
36. Calvanese V, Fernández AF, Urdinguio RG, Suárez-Alvarez B, Mangas C, Pérez-García V, Bueno C, Montes R, Ramos-Mejía V, Martínez-Camblor P, et al. A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res 2012; 40:116-31; PMID:21911366; http:// dx.doi.org/10.1093/nar/gkr685
37. Delgado MD, León J. Myc roles in hematopoiesis and leukemia. Genes Cancer 2010; 1:605-16; PMID:21779460; http://dx.doi. org/10.1177/1947601910377495
38. He C, Hu H, Braren R, Fong SY, Trumpp A, Carlson TR, Wang RA. c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo. Development 2008; 135:2467-77; PMID:18550710; http://dx.doi.org/10.1242/ dev.020131
39. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR, Trumpp A. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004; 18:2747-63; PMID:15545632; http://dx.doi.org/10.1101/ gad.313104
40. Montes R, Ligero G, Sanchez L, Catalina P, de la Cueva T, Nieto A, Melen GJ, Rubio R, García-Castro J, Bueno C, et al. Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-beta and IGF-II. Cell Res 2009; 19:698-709; PMID:19308090; http://dx.doi. org/10.1038/cr.2009.35
41. Choi KD, Vodyanik M, Slukvin II. Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc 2011; 6:296-313; PMID:21372811; http://dx.doi. org/10.1038/nprot.2010.184
42. Real PJ, Ligero G, Ayllon V, Ramos-Mejia V, Bueno C, Gutierrez-Aranda I, Navarro-Montero O, Lako M, Menendez P. SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells. Mol Ther 2012; 20:1443-53; PMID:22491213; http:// dx.doi.org/10.1038/mt.2012.49
43. Ji J, Vijayaragavan K, Bosse M, Menendez P, Weisel K, Bhatia M. OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells. Stem Cells 2008; 26:2485-95; PMID:18669904; http://dx.doi.org/10.1634/stemcells.2008-0642
44. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 2004; 101:12543-8; PMID:15310843; http://dx.doi. org/10.1073/pnas.0404700101
45. Bueno C, Montes R, Martín L, Prat I, Hernandez MC, Orfao A, Menendez P. NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered? Leukemia 2008; 22:1475-8; PMID:18698324; http://dx.doi.org/10.1038/leu.2008.134
46. Bueno C, Catalina P, Melen GJ, Montes R, Sánchez L, Ligero G, García-Pérez JL, Menendez P. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis 2009; 30:1628-37; PMID:19587093; http://dx.doi.org/10.1093/carcin/bgp169
47. Schweiger MR, You J, Howley PM. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol 2006; 80:4276-85; PMID:16611886; http://dx.doi.org/10.1128/ JVI.80.9.4276-4285.2006